Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,491 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Anchorage Digital is introducing institutional custody for TRX, a regulatory milestone that could reshape near-term p...
Insider buying can hint at confidence from leadership, but it isn’t a crystal ball. This guide explains how to interp...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
North Korea’s Foreign Ministry rejected cyber theft accusations as 'absurd slander,' arguing the claims are political...
Kennametal’s Q3 2026 results shed light on the company’s path through a challenging manufacturing environment. This a...
Investors are watching Friday’s April payroll report for signs that businesses really starting hire signals a broader...
As HubSpot prepares to report its 2026 earnings, investors want clarity on growth drivers, profitability, and strateg...
Anthropic reports an unprecedented 80-fold increase in annualized usage for Q1, fueling a rapid expansion that includ...
The SEC outlines a two-stage approach to on-chain trading, echoing lessons from the 1990s as it weighs how crypto ven...
Mozilla’s latest security push uses Mythos AI to slash a year of fixes into one month, highlighting how AI-assisted d...
Arm Holdings’ stock has jumped sharply this year on AI data center demand, yet a valuation gap and monetization hurdl...